Abstract: The present application discloses pharmaceutical compositions for modified release of huperzine. The pharmaceutical compositions and methods described herein, allow for dosing of huperzine at higher therapeutic thresholds, while avoiding rapid serum peak plasma levels, thereby avoiding the adverse nausea and vomiting associated with the immediate release pharmaceutical compositions. Methods of treating neurological disorders and/or seizure disorders with the modified release compositions is also described.
Type:
Application
Filed:
July 28, 2021
Publication date:
November 18, 2021
Applicant:
Biscayne Neurotherapeutics, Inc.
Inventors:
Stephen D. Collins, Peter Goldstein, Joshua T. Johnstone